Member Info for Mnemosyne

Quietly regaining lost ground in the last couple of days. Those couple of biggish buyers between Christmas and New Year must be smiling to themselves.

Me opening my big mouth on a board is usually a signal for the SP to head south, so I haven't been interrupting you either. But rest assured there's someone else out here with their fingers crossed, waving a little flag.

Must be anticipating reasonable results tomorrow. No complaints here.

This still counts as "early in the new year". Are we about to see the promised update, do you reckon? SP suggests something's afoot.

This SP has doubled in a month now. Coming back from a low low, but even so it's really encouraging to see. Let's hope the news is positive enough to maintain this confidence when it comes.

Put it this way ... Just passed up the kind offer from my current supplier to fix for 2 years at the outrageous rate they want to charge now my previous tariff has been withdrawn. If it is Tesco plus Bgbl and they are about to launch something high profile, there may be competitive tariffs for new customers. A boost to my BGBL holding plus a better deal on my electricity and gas would be a nice way to start the New Year.

OK, a funny trading day all round and a largeish movement on what is pretty low volume, but all the same I do wonder whether we're starting to see some anticipation of news. The wording was "As mentioned in our recent trading update, the Group is currently working with an experienced retail player to establish a new energy supplier that will enter the market at scale. I am pleased to report that we are making good progress in these discussions and I hope to be able to provide further details about this transaction early in the New Year." If so, then not too long to wait.

19 December 2011 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Acquisition of Dermatology Brands Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that its wholly owned subsidiary Alliance Pharmaceuticals Limited has acquired the brands QuinodermTM and CeanelTM from Ferndale Pharmaceuticals Limited for £1.5m cash consideration. Quinoderm is a well-established medication for the treatment of acne and Ceanel is a shampoo treatment for scalp psoriasis. For the twelve months ended 30 September 2011 the acquired products had total sales of approximately £0.6 million. Alliance is funding the acquisition by drawing a loan from the £20m Revolving Credit Facility ("RCF") put in place in November 2010 to fund acquisitions. This brings the current utilisation of the RCF to £6.5m. Commenting on the acquisition, John Dawson, Alliance Pharma's Chief Executive, said: "We are delighted to announce this acquisition, which extends our Dermatology portfolio. Quinoderm complements our existing product Rizuderm (isotretinoin), a treatment for severe acne acquired in September this year. "Today's acquisition, which represents our third transaction this year, is expected to be earnings enhancing in 2012. We continue to evaluate further opportunities to broaden our product portfolio."

Hmm, was thinking along the same (Tesco) lines myself after reading the last trading update. I'm well down on this one, having been in for a couple of years on the back of the old smart meter rollout expectations, but I'm sitting tight for now. I don't expect December's figures to light any fireworks, but a successful tie-up with a credible new national power retailer could give us a very different story.

Happy to see these results. This has been a solid, safe share for me amid the turmoil of this year. Good growth, and a handy if modest dividend. Nothing is ever certain, but you know what they say about death (and taxes, unfortunately).

BGLOBAL PLC ("Bglobal" or the "Company" or the "Group") Preliminary Results for the year ended 31 March 2011 Bglobal plc (AIM: BGBL), the leading provider of smart energy solutions and services to the UK energy market, announces its preliminary results for the year ended 31 March 2011. Highlights: · Revenue increased by 119.1 per cent to £28.99 million (2010: £13.23 million) · Services revenues increased 148.2 per cent to £5.56 million (2010: £2.24 million) · Adjusted EBITDA1 £4.16 million (2010: £0.01 million) · Adjusted profit before taxation1 £3.81 million (2010: £0.47 million loss) · Basic loss per share 1.51p (2010: 0.49p loss) · Adjusted earnings per share1 3.26p (2010: 0.02p loss) · Net cash generated from operations £2.32 million (2010: £0.10 million outflow) · Net funds of £6.42 million raised in an equity placing and open offer June 2010 · Acquisition of Utiligroup completed June 2010. · More than 155,000 total smart meters now installed · Over 66,000 meter installations billed in the financial year 1Before the charge of £2.92 million arising from the contingent consideration and £0.19 million of acquisition costs relating to the acquisition of Utiligroup, share based charges of £0.14 million and amortisation of acquired intangibles of £1.22 million. Tim Jackson Smith, Group Chief Executive of Bglobal, commented: "The year ended 31 March 2011 has seen the Group pass a number of key milestones - in June 2010 we made our first acquisition and Bglobal Metering has delivered a maiden profit. It is also pleasing to be able to report that the Group has been cash generative throughout the period and that all parts of the Group have performed well. The markets we operate in are undergoing major change, with Government announcing its plans for the mass rollout of smart meters and beginning to challenge the dominance of the Big 6 energy suppliers by calling for more new entrants to help create a more competitive environment. All of these changes present significant opportunities for the Group and the services and solutions we are able to offer mean we are well placed to take advantage of them." -end-

The market seems disappointed, but I'm not sure why, unless expectations were totally unrealistic. We knew there would be fallout from the debt refinancing, but it looks like the worst of that is behind the company barring accidents. Turnover and operating profit are up in a sector particularly vulnerable to the slump; it appears management have a tight grip on the finances and an ongoing strategy to steer the company through the bad times. These stay in the bottom drawer for me.

Especially pleased to see another Optim unit has been ordered - that's the sixth since the New Year (at £92500 each, plus recurring consumables thereafter) - and into a new market too. Won't hurt this year's bottom line at all.

These brands will sit nicely in APH's growing portfolio. Looking at the potential revenue, the borrowings to fund the purchase do not appear excessive.

Bought another 1.3m on the back of the Samsung RNS, it seems. Institutionals seem to like what they see this week. http://www.investegate.co.uk/article.aspx?id=201102171749294536B&fe=1

http://www.bloomberg.com/news/2011-02-09/most-asian-stocks-rise-as-earnings-improve-toyota-commonwealth-bank-gain.html

Sounds very promising. "Cold Spring is a market leading life sciences distribution company headquartered in Taiwan (offices in Taipei, Taichung, and Tainan) with commercial operations throughout Hong Kong and mainland China (offices in Beijing, Shanghai, Guangzhou, Chengdu, and Wuhan). Founded in 1983 they are established distributors with many years of experience in selling high value instrumentation and consumables in the rapidly growing Asian Biotech and Life Sciences market, representing major technology innovators such as Affymetrix and Caliper Life Sciences. The Chinese biotech market is now the fastest growing biotech market worldwide and the Chinese government expects it to grow 24.1% between 2011 and 2015. "

Thanks for that. I've been scratching my head, looking for a clue to why this has fallen recently - nice to see at least one analyst out there agrees it's reliable, solid and undervalued.

Funny. Arrogance was a word I deliberately avoided using in my last post, as I was trying to explain the reasons for my misgivings about your sudden appearance and postings, rather than to offer assumptions about your character. And I haven't commented - and wouldn't dream of doing so - on your spelling, other than to repeat that it sets my alarm bells ringing when someone seems to imply a closer connection with a company or its directors than your ordinary PI, but makes a basic error with one of their names - it could be an honest typo, but it makes me wonder. Perhaps it will make things clearer if I explain that there was an incident on a board I watch a year or two ago, with a poster who suddenly appeared, started posting reams of info that had been cherry-picked for its positive slant (much of which was out of date and recycled) and kept a bunch of relative newbies enthralled for weeks with his tales of a significant holding, visits to head office and snippets of info from his email conversations with directors, and his confident projections for the future based on what he said he knew and saw. He was called out by some of the more experienced regulars, of course, (not me, incidentally - I was fortunate to be a watcher rather than an investor on that occasion, but I learned a lot). It got rather heated, but he persisted and created quite a buzz, perhaps enough to account for the increased volume and rising SP in the short term. When it all went pear-shaped, as it did, he vanished, but some had been daft enough to plunge a lot deeper than they should in the meantime. Yes, you can say it was their own fault, and of course it was. You DYOR, make your own decisions, take responsibility for them, and accept any consequences. But it left me with a kneejerk, perhaps unjustified, suspicion about that pattern of behaviour when I think I see it starting up somewhere. I sincerely hope you are a fellow investor, in for the long term and pretty confident about Avacta's future, because the more of us there are, the better for the company. And if you do visit York, get to see the business plan and hear directors' own analysis of the current position, and feel this gives you more ammunition for your own decisions, the very best of luck to you. I think my predictions about Avacta's future are worthless to anyone but me; others will have to gaze into their own crystal ball. But if I didn't think this was a sound investment and getting sounder, I wouldn't be here.

Well, the point about the links was that they were already posted here in plain view, along with a fair amount of other useful and informative items, linked or posted here as they were released. Either you dismissed them completely or didn't spot them during your trawl back over the board's history; your comments basically amount to "nobody's bothered to post anything useful here before". Rubbishing the good-faith contributions of others, however modest, doesn't show your courteous side, although I'm sure you have one. From what you've said you claim to have around £90k in the company, which would equate to somewhere in the region of 0.75%-0.85% of the share capital if you bought your biggest tranche at the end of October as you suggest. That's a significant PI holding, but you post old news as though it were the latest and don't seem aware of more recent items. As for the thing with the name, you say the CFO's prepared to meet you for a chat:; you casually name-drop the CEO as though you know him personally: but you spell his name wrong. The thing about exceptional claims is that they require exceptional proofs. Since we can none of us produce an ounce of proof that we are who we say we are, hold the shares we claim to hold, or know who and what we claim to know, that sort of thing just rings alarm bells and makes people suspicious. Sad? No. Cautious? Definitely. Believe Avacta has potential? I wouldn't be invested if I didn't. But the only information I pay attention to is what the company publishes, or that which I can confirm independently for myself.